Verified email-pattern data for Orinova is currently limited. You can still use the company insights and contact sections below.
FR : ORINOVA développe des nano médicaments en oncologie selon une invention mise au point par deux équipes de recherche de l’université de Franche- Comté.
L’innovation ORINOVA repose sur une bithérapie : chimiothérapie et radiothérapie qui agissent simultanément et de façon synergique. Ce médicament est véhiculé dans une nanosphère intelligente qui contient une molécule de chimiothérapie et des particules d’or augmentant l’efficacité de la radiothérapie.
Ce nano-objet innovant breveté montre un fort potentiel pour traiter les tumeurs solides sans solution thérapeutique satisfaisante comme le glioblastome (7% de survie à 5 ans) et présente des résultats préliminaires très prometteurs dans cette indication.
Outre l’efficacité programmée du traitement ORINOVA celui-ci permet aussi une forte diminution des effets secondaires puisque la radiothérapie sera bien mieux ciblée et donc moins délétère à la fois en termes d’intensité des rayons administrés que de la préservation des tissus sains situés autour de la tumeur.
---------------------------------------------------------------------------------
EN : ORINOVA is developing nano-medicines for oncology, based on an invention from two research teams at the University of Franche-Comté.
Our innovation combines chemotherapy and radiotherapy in a synergistic dual therapy, delivered through an intelligent nanosphere. This nanosphere carries a chemotherapy molecule along with gold nanoparticles that enhance radiotherapy effectiveness.
This patented nano-object holds strong potential for treating solid tumors with limited therapeutic options, such as glioblastoma (5-year survival rate: 7%), and has already shown highly promising preliminary results.
Beyond its planned therapeutic efficacy, ORINOVA’s treatment significantly reduces side effects by enabling more precise targeting of radiotherapy, minimizing both radiation intensity and damage to surrounding healthy tissues.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Besançon , 25000, Fr
- Industry
- Pharmaceutical Manufacturing
- HQ
- Besançon
Orinova Questions
ORINOVA's LinkedIn profile is https://fr.linkedin.com/company/or-inova
ORINOVA has
5 employees.
View email and phone details for 5
employees at ORINOVA.
ORINOVA's industry is
Pharmaceutical Manufacturing
ORINOVA's top competitors are
Letsee Imaging,
Cytea Bio,
Yomi Pharma,
See2cure,
Minos Biosciences,
Areltys,
Innov'ncare,
Abtx,
React Therapeutics,
Microxpace.
ORINOVA's categories are Pharmaceutical Manufacturing
ORINOVA's founding year is 2024
Top ORINOVA Employees
-
-
Gautier Laurent
Co-Fondateur Orinova
Bourgogne-Franche-Comté, France, France1univ-fcomte.fr -
-
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.